Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) EBITDA Margin: 2009-2025

Historic EBITDA Margin for Prestige Consumer Healthcare (PBH) over the last 17 years, with Mar 2025 value amounting to 18.58%.

  • Prestige Consumer Healthcare's EBITDA Margin fell 521.00% to 15.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.63%, marking a year-over-year decrease of 176.00%. This contributed to the annual value of 18.58% for FY2025, which is 24.00% up from last year.
  • Prestige Consumer Healthcare's EBITDA Margin amounted to 18.58% in FY2025, which was up 1.32% from 18.34% recorded in FY2024.
  • Prestige Consumer Healthcare's EBITDA Margin's 5-year high stood at 20.04% during FY2021, with a 5-year trough of -8.41% in FY2023.
  • For the 3-year period, Prestige Consumer Healthcare's EBITDA Margin averaged around 9.51%, with its median value being 18.34% (2024).
  • As far as peak fluctuations go, Prestige Consumer Healthcare's EBITDA Margin slumped by 2,738bps in 2023, and later skyrocketed by 2,675bps in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's EBITDA Margin (Yearly) stood at 20.04% in 2021, then tumbled by 107bps to 18.97% in 2022, then slumped by 2,738bps to -8.41% in 2023, then soared by 2,675bps to 18.34% in 2024, then climbed by 24bps to 18.58% in 2025.